The influence of smoking on the intersubject variation in pentazocine elimination.
- 1 April 1976
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 3 (2), 279-283
- https://doi.org/10.1111/j.1365-2125.1976.tb00604.x
Abstract
The cumulative urinary excretion over 24 h of pentazocine, under conditions of acidic urinary pH, has been measured in smokers and non‐ smokers using both male and female subjects (seventy subjects in total). A restricted urban population was studied. An overall three‐ fold inter‐subject variation in elimination was observed. The cumulative urinary excretion of pentazocine was normally distributed in both smokers and non‐smokers. Smokers metabolize 40% more pentazocine than non‐smokers. It is concluded that induction is principally responsible for the observed subject variability.Keywords
This publication has 11 references indexed in Scilit:
- Effect of cigarette smoking on phenacetin metabolismClinical Pharmacology & Therapeutics, 1974
- Decreased clinical efficacy of propoxyphene in cigarette smokersClinical Pharmacology & Therapeutics, 1973
- THE ABSORPTION AND EXCRETION OF PENTAZOCINE AFTER ADMINISTRATION BY DIFFERENT ROUTESBritish Journal of Anaesthesia, 1971
- ATMOSPHERIC POLLUTION AND PENTAZOCINE METABOLISM*1The Lancet, 1971
- Pharmacokinetic Studies on PentazocineActa Pharmacologica et Toxicologica, 1971
- Metabolism in vitro and in vivo of pentazocineBiochemical Pharmacology, 1969
- Relationship of pentazocine plasma levels to pharmacological activity in manClinical Pharmacology & Therapeutics, 1969
- Enzyme Induction in Man caused by SmokingNature, 1967